Tecan provides automated solutions for molecular pharmacology

The Leibniz-Institut für Molekulare Pharmakologie in Berlin, Germany, is using Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries, looking for potential research tools and targets for drug development.
Dr Jens Peter von Kries, Head of the Institute’s Screening Unit, explained: "The Screening Unit has a small team of staff performing library screens of around 20,000 compounds a day, and this high throughput is partly thanks to the flexibility of our Freedom EVO workstations. Many of our projects use either high content screening with automated microscopes or genome-wide RNA interference (RNAi) studies, and we have a Freedom EVO system configured for each of these methods, as well as a platform equipped with a REMP Small Size Store™ for management of the ChemBioNet screening library."

 

"Each workstation has been collaboratively designed with the Tecan Integration Group (TIG) to create a robust system that is capable of high throughput analysis, giving consistent results even with long term use. The approval procedure is central to this process, with both factory and site acceptance tests to guarantee that the platform exactly matches our needs. Tecan is very willing to support us with development of the platforms as new technologies become available, and we enjoy a very good working relationship with the company’s automation engineers, receiving immediate expert support for all our projects. Tecan has an exceptional culture of customer service, and our work here at the FMP undoubtedly benefits from this close partnership."

 

To find out more on Tecan’s Freedom EVO workstations, visit www.tecan.com/freedomevo
To find out more on Tecan Integration Group, visit www.tecan.com/tig
To find out more on ChemBioNet or FMP, please visit www.chembionet.org or www.fmp-berlin.de

 

 

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).

 

 

For more information about Tecan, please contact

T +41 44 922 81 11
F +41 44 922 81 12

info@tecan.com
www.tecan.com